Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, Sondheimer SJ, Hendrix SL, Amortegui A, Trucco G, Songer T, Lave JR, Hillier SL, Bass DC, Kelsey SF.

Am J Obstet Gynecol. 2002 May;186(5):929-37.

PMID:
12015517
2.

Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.

Ness RB, Trautmann G, Richter HE, Randall H, Peipert JF, Nelson DB, Schubeck D, McNeeley SG, Trout W, Bass DC, Soper DE.

Obstet Gynecol. 2005 Sep;106(3):573-80. Erratum in: Obstet Gynecol. 2006 Jun;107(6):1423-5.

PMID:
16135590
3.

Design of the PID Evaluation and Clinical Health (PEACH) Study.

Ness RB, Soper DE, Peipert J, Sondheimer SJ, Holley RL, Sweet RL, Hemsell DL, Randall H, Hendrix SL, Bass DC, Kelsey SF, Songer TJ, Lave JR.

Control Clin Trials. 1998 Oct;19(5):499-514.

PMID:
9741869
4.

Adherence to oral therapies in pelvic inflammatory disease.

Dunbar-Jacob J, Sereika SM, Foley SM, Bass DC, Ness RB.

J Womens Health (Larchmt). 2004 Apr;13(3):285-91.

PMID:
15130257
5.
6.

Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.

Kosseim M, Ronald A, Plummer FA, D'Costa L, Brunham RC.

Antimicrob Agents Chemother. 1991 Aug;35(8):1651-6.

7.

Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.

Haggerty CL, Ness RB, Amortegui A, Hendrix SL, Hillier SL, Holley RL, Peipert J, Randall H, Sondheimer SJ, Soper DE, Sweet RL, Trucco G.

Am J Obstet Gynecol. 2003 Jan;188(1):141-8.

PMID:
12548208
8.

Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline.

Wølner-Hanssen P, Paavonen J, Kiviat N, Young M, Eschenbach DA, Holmes KK.

Obstet Gynecol. 1988 Apr;71(4):595-600.

PMID:
3353051
9.

Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.

Sweet RL, Schachter J, Landers DV, Ohm-Smith M, Robbie MO.

Am J Obstet Gynecol. 1988 Mar;158(3 Pt 2):736-41.

PMID:
3162653
10.

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.

Haggerty CL, Totten PA, Astete SG, Lee S, Hoferka SL, Kelsey SF, Ness RB.

Sex Transm Infect. 2008 Oct;84(5):338-42. doi: 10.1136/sti.2008.030486. Epub 2008 Apr 29.

11.

Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.

McGregor JA, Crombleholme WR, Newton E, Sweet RL, Tuomala R, Gibbs RS.

Obstet Gynecol. 1994 Jun;83(6):998-1004.

PMID:
8190448
12.

Outpatient pelvic inflammatory disease treatment as effective as inpatient care, study finds.

Levenson D.

Rep Med Guidel Outcomes Res. 2002 Jun 14;13(11):9-10, 12. No abstract available.

PMID:
12498174
15.

Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.

Hemsell DL, Little BB, Faro S, Sweet RL, Ledger WJ, Berkeley AS, Eschenbach DA, Wölner-Hanssen P, Pastorek JG 2nd.

Clin Infect Dis. 1994 Oct;19(4):720-7.

PMID:
7803638
16.

Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.

Roy S, Koltun W, Chatwani A, Martens MG, Dittrich R, Luke DR.

Am J Surg. 1998 Dec;176(6A Suppl):67S-73S.

PMID:
9935260
17.

Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.

Heinonen PK, Leinonen M.

Arch Gynecol Obstet. 2003 Oct;268(4):284-8. Epub 2002 Oct 26.

PMID:
14504870
18.

Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.

Savaris RF, Teixeira LM, Torres TG, Edelweiss MI, Moncada J, Schachter J.

Obstet Gynecol. 2007 Jul;110(1):53-60.

PMID:
17601896
19.
20.

Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy.

Burnakis TG, Hildebrandt NB.

Rev Infect Dis. 1986 Jan-Feb;8(1):86-116. Review.

PMID:
2937130
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk